Literature DB >> 22328553

Age-dependent lethality in novel transgenic mouse models of central nervous system arteriovenous malformations.

Ian Milton1, Dan Ouyang, Caitlin J Allen, Nathan E Yanasak, James R Gossage, Cargill H Alleyne, Tsugio Seki.   

Abstract

BACKGROUND AND
PURPOSE: The lack of an appropriate animal model has been a limitation in studying hemorrhage from arteriovenous malformations (AVMs) in the central nervous system.
METHODS: Novel mouse central nervous system AVM models were generated by conditionally deleting the activin receptor-like kinase (Alk1; Acvrl1) gene with the SM22-Cre transgene. All mice developed AVMs in their brain and/or spinal cord, and >80% of them showed a paralysis or lethality phenotype due to internal hemorrhages during the first 10 to 15 weeks of life. The mice that survived this early lethal period, however, showed significantly reduced lethality rates even though they carried multiple AVMs.
RESULTS: The age-dependent change in hemorrhage rates allowed us to identify molecular factors uniquely upregulated in the rupture-prone AVM lesions.
CONCLUSIONS: Upregulation of angiopoietin 2 and a few inflammatory genes were identified in the hemorrhage-prone lesions, which may be comparable with human pathology. These models will be an exceptional tool to study pathophysiology of AVM hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22328553     DOI: 10.1161/STROKEAHA.111.647024

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  24 in total

1.  Integrin β8 Deletion Enhances Vascular Dysplasia and Hemorrhage in the Brain of Adult Alk1 Heterozygous Mice.

Authors:  Li Ma; Fanxia Shen; Kristine Jun; Chen Bao; Robert Kuo; William L Young; Stephen L Nishimura; Hua Su
Journal:  Transl Stroke Res       Date:  2016-06-29       Impact factor: 6.829

2.  De novo cerebrovascular malformation in the adult mouse after endothelial Alk1 deletion and angiogenic stimulation.

Authors:  Wanqiu Chen; Zhengda Sun; Zhenying Han; Kristine Jun; Marine Camus; Mamta Wankhede; Lei Mao; Tom Arnold; William L Young; Hua Su
Journal:  Stroke       Date:  2014-01-23       Impact factor: 7.914

Review 3.  The pathobiology of vascular malformations: insights from human and model organism genetics.

Authors:  Sarah E Wetzel-Strong; Matthew R Detter; Douglas A Marchuk
Journal:  J Pathol       Date:  2016-12-04       Impact factor: 7.996

4.  Mouse Models of Cerebral Arteriovenous Malformation.

Authors:  Corinne M Nielsen; Lawrence Huang; Patrick A Murphy; Michael T Lawton; Rong A Wang
Journal:  Stroke       Date:  2015-09-08       Impact factor: 7.914

5.  Endothelial signaling and the molecular basis of arteriovenous malformation.

Authors:  Deepak Atri; Bruno Larrivée; Anne Eichmann; Michael Simons
Journal:  Cell Mol Life Sci       Date:  2013-09-28       Impact factor: 9.261

Review 6.  Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets.

Authors:  Wanqiu Chen; Eun-Jung Choi; Cameron M McDougall; Hua Su
Journal:  Transl Stroke Res       Date:  2014-04-12       Impact factor: 6.829

7.  Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology.

Authors:  Santiago Ruiz; Pallavi Chandakkar; Haitian Zhao; Julien Papoin; Prodyot K Chatterjee; Erica Christen; Christine N Metz; Lionel Blanc; Fabien Campagne; Philippe Marambaud
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

8.  Translating basic science research to clinical application: models and strategies for intracerebral hemorrhage.

Authors:  Christopher C Leonardo; Sean Robbins; Sylvain Doré
Journal:  Front Neurol       Date:  2012-05-29       Impact factor: 4.003

Review 9.  Mouse models of vascular development and disease.

Authors:  Ondine Cleaver
Journal:  Curr Opin Hematol       Date:  2021-05-01       Impact factor: 3.218

Review 10.  Review of treatment and therapeutic targets in brain arteriovenous malformation.

Authors:  Peipei Pan; Shantel Weinsheimer; Daniel Cooke; Ethan Winkler; Adib Abla; Helen Kim; Hua Su
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-23       Impact factor: 6.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.